Peptide Therapy in New Jersey
Tirzepatide
Tirzepatide is a peptide therapy currently in clinical trials for treating type 2 diabetes and obesity. It works by activating the GLP-1 and GIP receptors, improving blood sugar control and weight loss. Early studies have shown promising results with fewer side effects than other GLP-1 agonists.
Phendimetrazine (Bontril)
Phendimetrazine, also known as Bontril, is a prescription weight loss medication. It suppresses appetite and increases metabolism by releasing norepinephrine in the brain. It is typically used as a short-term treatment for obesity and is often prescribed with diet and exercise.
Contrave
Contrave is a peptide therapy used in the treatment of obesity. It combines bupropion and naltrexone to suppress appetite and reduce cravings for food and alcohol. It has been shown to promote weight loss and improve cardiovascular health effectively but may cause side effects such as nausea and headaches.
Benzphetamine (Didrex)
Didrex, or Benzphetamine, is a prescription drug used for weight loss. By stimulating the release of norepinephrine in the brain, it reduces appetite and boosts metabolism. It is commonly prescribed as a short-term solution for obesity and is typically accompanied by a healthy diet and exercise regimen.
GW-501516
GW-501516, also known as Cardarine, is a peptide therapy studied for its potential in improving endurance and fat burning. It works by activating the PPAR-delta pathway, which increases the expression of genes involved in energy metabolism.
MK-2866
MK-2866, also known as Ostarine, is a peptide therapy in New Jersey studied for its potential in treating muscle wasting and osteoporosis. It works by selectively targeting androgen receptors in the body, increasing muscle mass and bone density.
